Paolo Calabria

Showing 1-2 of 2 articles

Coronary interventions

One-year clinical results of the Italian diffuse/multivessel disease ABSORB prospective registry (IT-DISAPPEARS)

Testa L, De Carlo M, Petrolini A, Rapetto C, Varbella F, Cortese B, Gabrielli G, Geraci S, Loi B, Boccuzzi G, Tarantini G, Fischetti D, Calabria P, Tomai F, Ribichini F, Tamburino C, Indolfi C, Bartorelli A, Petronio A, Bedogni F

July 20, 2017 | 10.4244/EIJ-D-17-00246

One-year outcomes in unselected patients treated with a thin-strut, platinum-chromium, paclitaxel-eluting stent: primary endpoint results from the TAXUS Element European post-approval surveillance study (TE-PROVE)

Tamburino C, Capodanno D, Erglis A, Menown I, Horvath I, Moreno R, Gilbert T, Crowley J, Calabria P, Allocco D, Dawkins K

March 20, 2015 | 10.4244/EIJY15M01_01

1

Latest news

LM revascularisation, annulus rupture, risk stratification, renal denervation

Introducing the new Editorial Board

This week's JAA's: Right pulmonary artery to left atrium fistula, BRS in high-risk patients

This week’s JAA’s: VIV-TAVR outcomes, Failing homograft AVR: 5 year outcomes...

Predicting the Future for LM Revascularization? Choosing the Right Fortune Teller…

Philippe Généreux

Guidance Papers

Guidelines, consensus & position papers

Radiofrequency renal denervation is effective - and safe?

Coronary

Valvular disease

Heart failure

Peripheral

Hypertension

Stroke